Cargando…

Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development

Alzheimer’s disease (AD) is one of the major reasons for 60-80% cases of senile dementia occurring as a result of the accumulation of plaques and tangles in the hippocampal and cortical neurons of the brain leading to neurodegeneration and cell death. The other pathological features of AD comprise a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatia, Shiveena, Rawal, Rishi, Sharma, Pratibha, Singh, Tanveer, Singh, Manjinder, Singh, Varinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878959/ https://www.ncbi.nlm.nih.gov/pubmed/33998995 http://dx.doi.org/10.2174/1570159X19666210517114016

Ejemplares similares

Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
por: Bhatia, Shiveena, et al.
Publicado: (2023)

Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
por: Sharma, Pratibha, et al.
Publicado: (2023)

In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)
por: Goyal, Shuchi, et al.
Publicado: (2023)

Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds
por: Singh, Varinder, et al.
Publicado: (2023)

BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors
por: Patel, Smith, et al.
Publicado: (2022)

Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer's Disease
por: Hroudová, Jana, et al.
Publicado: (2014)

Predictors of Hospitalization for Manic Episode in Alzheimer’s Dementia: Inputs From an Inpatient Case-Control Study
por: Nandwana, Varsha, et al.
Publicado: (2021)

Alzheimer’s disease: a mini-review for the clinician
por: Madnani, Rishi S.
Publicado: (2023)

Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities
por: Brem, Anna-Katharine, et al.
Publicado: (2023)

Mitochondrial Cholesterol in Alzheimer's Disease and Niemann–Pick Type C Disease
por: Torres, Sandra, et al.
Publicado: (2019)

Krabbe Disease Associated With Mitochondrial Dysfunction in a Chinese Family
por: Wu, Liwen, et al.
Publicado: (2021)

Design Strategies, Chemistry and Therapeutic Insights of Multi-target Directed Ligands as Antidepressant Agents
por: Singh, Karanvir, et al.
Publicado: (2022)

Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer’s Disease
por: de Sousa, Natália Ferreira, et al.
Publicado: (2022)

Development of a Multicomponent Intervention to Prevent Alzheimer's Disease
por: Saito, Satoshi, et al.
Publicado: (2019)

Sleep deficiency promotes Alzheimer's disease development and progression
por: Lv, Ya-Nan, et al.
Publicado: (2022)

Potential Roles of α-amylase in Alzheimer’s Disease: Biomarker and Drug Target
por: Chen, Win Ning, et al.
Publicado: (2022)

Bulbar Dysfunction in Idiopathic Normal Pressure Hydrocephalus: A Case Report
por: Usama, Muhammad, et al.
Publicado: (2023)

Late Presentation of Hirayama Disease With “Snake Eye Sign”: A Case Report
por: Mishra, Sarvesh C, et al.
Publicado: (2022)

Diagnostic models and predictive drugs associated with cuproptosis hub genes in Alzheimer's disease
por: Zhang, Erdong, et al.
Publicado: (2023)

New Therapeutics in Alzheimer’s Disease Longitudinal Cohort study (NTAD): study protocol
por: Lanskey, Juliette Helene, et al.
Publicado: (2022)

RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease
por: Awasthi, Sanjay, et al.
Publicado: (2021)

Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease
por: Ashraf-Ganjouei, Amir, et al.
Publicado: (2018)

The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
por: Kilzheimer, Alexander, et al.
Publicado: (2019)

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
por: Corbett, Anne, et al.
Publicado: (2013)

Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China
por: Cao, Yuxia, et al.
Publicado: (2022)

Efficacy of Ferulic Acid in an Animal Model of Drug-Resistant Epilepsy: Beneficial or Not?
por: Thapliyal, Surabhi, et al.
Publicado: (2022)

Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics
por: Nabi, Showkat Ul, et al.
Publicado: (2023)

Airport smoking zones: a prospective public health hazard
por: Singh, Ravinder, et al.
Publicado: (2023)

The Flip Side of Distractibility—Executive Dysfunction in Functional Movement Disorders
por: Huys, Anne-Catherine M. L., et al.
Publicado: (2020)

Comprehensive Profile of Acute Mitochondrial Dysfunction in a Preclinical Model of Severe Penetrating TBI
por: Pandya, Jignesh D., et al.
Publicado: (2019)

Parkinson's Disease Research on the African Continent: Obstacles and Opportunities
por: Dekker, Marieke C. J., et al.
Publicado: (2020)

Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
por: García-Escudero, Vega, et al.
Publicado: (2013)

Effect of antiamyloid-β drugs on Alzheimer’s disease: study protocol for a systematic review and meta-analysis
por: Lyu, Diyang, et al.
Publicado: (2021)

Clinical Significance of Adropin and Afamin in Evaluating Renal Function and Cardiovascular Health in the Presence of CKD-MBD Biomarkers in Chronic Kidney Disease
por: Kaur, Rupinder, et al.
Publicado: (2023)

Alzheimer´s Disease in the Perspective of Neuroimmunology
por: Maccioni, Ricardo B., et al.
Publicado: (2018)

Tau Ubiquitination in Alzheimer's Disease
por: Li, Longfei, et al.
Publicado: (2022)

Severe Form of ßIV-Spectrin Deficiency With Mitochondrial Dysfunction and Cardiomyopathy—A Case Report
por: Belkheir, Aziza Miriam, et al.
Publicado: (2021)

BHARAT: An Integrated Big Data Analytic Model for Early Diagnostic Biomarker of Alzheimer's Disease
por: Sharma, Ankita, et al.
Publicado: (2019)

Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities
por: Liguori, Sara, et al.
Publicado: (2021)

Elucidating the Interactive Roles of Glia in Alzheimer's Disease Using Established and Newly Developed Experimental Models
por: Chun, Heejung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_76nf6kdv6fcuip3d9us9hhubk5